A decade of healthcare improvement in cystic fibrosis: lessons for other chronic diseases
- 1The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire, USA
- 2The Cystic Fibrosis Foundation, Bethesda, Maryland, USA
- Correspondence to David P Stevens, The Dartmouth Institute for Health Policy and Clinical Practice, 30 Lafayette Street, Lebanon, NH 03756, USA;
- Received 25 January 2014
- Accepted 27 January 2014
- Chronic Disease Management
- Healthcare Quality Improvement
- Quality Improvement Methodologies
From 2002 to 2012, the median predicted survival age for people with cystic fibrosis (CF) increased nearly 10 years—from 31.3 years to 41.1 years.1 ,2 Strategic efforts to improve care for CF marked this remarkable era. These efforts were supported by expert leadership among CF healthcare improvement professionals and resources from the CF Foundation. While process outcomes improved substantially—for example, more timely clinic visits, increased influenza immunisation rates, and more effective screening for associated problems such as depression and diabetes,1 ,2 clinical outcomes improved even more dramatically—notably, pulmonary function, nutritional status and predicted survival.
This supplement, Ten Years of Improvement Innovation in Cystic Fibrosis Care, captures the larger perspective of this comprehensive improvement initiative and reports representative CF care centre-level examples. It also identifies strategies to widen the circle of improvement professionals who successfully publish their innovative work in scholarly journals.3
What can be found in THIS supplement?